Markets & Regulations

Piramal acquires Kentucky-based CDMO for $30m

Piramal acquires Kentucky-based CDMO for $30m

By Zachary Brennan

India-based CMO Piramal has acquired US-based sterile injectable CDMO (contract development and manufacturing organization) Coldstream Laboratories for $30.65m.

Exclusive extract: 'On Immunity: An Inoculation' by Eula Biss

Exclusive extract: 'On Immunity: An Inoculation' by Eula Biss

By Fiona BARRY

In an exclusive extract from her recent book On Immunity: An Innoculation, author Eula Biss describes her exploration of the social history and cultural myths surrounding vaccines.To be in with a chance of winning a copy, enter BioPharma-Reporter.com's...

William Reed Business Media Holiday video

Festive Film

Happy Holidays 2014 from William Reed Business Media!

The holidays are fast upon us, so let’s put ‘business’ to one side and get into the festive mood. To keep in the spirit of things, we’ve got a ‘gift’ for you – enjoy. Happy Holidays!

Will this be the first of many biosimilars to hit the Indian market?

Ranbaxy launches India’s first Remicade biosimilar

By Zachary Brennan

Ranbaxy Laboratories has launched the monoclonal antibody Infimab, the first Remicade (Infliximab) biosimilar, in India -- which is the first what could be a few home-grown biosimilar launches.